Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Seksik

Showing results (141-150 of 183) with videos related to

Pageof 19
Sort By:
Journal of Crohn'S & Colitis|February 26, 2022
Impact of the Ileal Microbiota on Surgical Site Infections in Crohn's Disease: A Nationwide Prospective CohortClément Julien, Emré Anakok, Xavier Treton, et al.
Leukemia & Lymphoma|November 21, 2018
Gastrointestinal Behcet's-like disease with myelodysplastic neoplasms with trisomy 8: a French case series and literature reviewNadege Wesner, Louis Drevon, Alexis Guedon, et al.
Journal of Crohn'S & Colitis|March 24, 2017
Risk of Rectal Neoplasia after Colectomy and Ileorectal Anastomosis for Ulcerative ColitisMathieu Uzzan, Julien Kirchgesner, Nadia Oubaya, et al.
Microbiome|February 5, 2020
Fecal microbiota transplantation to maintain remission in Crohn's disease: a pilot randomized controlled studyHarry Sokol, Cecilia Landman, Philippe Seksik, et al.
Clinical and Translational Gastroenterology|July 31, 2023
Prevalence of and Factors Associated With Extraintestinal Manifestations and Their Remission in Inflammatory Bowel Disease: The EXTRA-Intestinal Manifestation Prospective Study From the Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube DigestifLucas Guillo, Guillaume Savoye, Aurélien Amiot, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2020
Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort studyPauline Wils, Philippe Seksik, Carmen Stefanescu, et al.
The American Journal of Gastroenterology|December 14, 2016
Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND GroupMathurin Fumery, Philippe Seksik, Claire Auzolle, et al.
Inflammatory Bowel Diseases|May 3, 2014
Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's diseaseSylvie Rajca, Virginie Grondin, Edouard Louis, et al.
Inflammatory Bowel Diseases|February 27, 2016
Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent MalignancyFlorian Poullenot, Philippe Seksik, Laurent Beaugerie, et al.
Gut|November 25, 2024
Top-down infliximab plus azathioprine versus azathioprine alone in patients with acute severe ulcerative colitis responsive to intravenous steroids: a parallel, open-label randomised controlled trial, the ACTIVE trialAurelien Amiot, Philippe Seksik, Antoine Meyer, et al.
Pageof 19

Showing results (141-150 of 183) with videos related to

Sort By:
Pageof 19
Journal of Crohn'S & Colitis|February 26, 2022
Impact of the Ileal Microbiota on Surgical Site Infections in Crohn's Disease: A Nationwide Prospective CohortClément Julien, Emré Anakok, Xavier Treton, et al.
Leukemia & Lymphoma|November 21, 2018
Gastrointestinal Behcet's-like disease with myelodysplastic neoplasms with trisomy 8: a French case series and literature reviewNadege Wesner, Louis Drevon, Alexis Guedon, et al.
Journal of Crohn'S & Colitis|March 24, 2017
Risk of Rectal Neoplasia after Colectomy and Ileorectal Anastomosis for Ulcerative ColitisMathieu Uzzan, Julien Kirchgesner, Nadia Oubaya, et al.
Microbiome|February 5, 2020
Fecal microbiota transplantation to maintain remission in Crohn's disease: a pilot randomized controlled studyHarry Sokol, Cecilia Landman, Philippe Seksik, et al.
Clinical and Translational Gastroenterology|July 31, 2023
Prevalence of and Factors Associated With Extraintestinal Manifestations and Their Remission in Inflammatory Bowel Disease: The EXTRA-Intestinal Manifestation Prospective Study From the Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube DigestifLucas Guillo, Guillaume Savoye, Aurélien Amiot, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2020
Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort studyPauline Wils, Philippe Seksik, Carmen Stefanescu, et al.
The American Journal of Gastroenterology|December 14, 2016
Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND GroupMathurin Fumery, Philippe Seksik, Claire Auzolle, et al.
Inflammatory Bowel Diseases|May 3, 2014
Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's diseaseSylvie Rajca, Virginie Grondin, Edouard Louis, et al.
Inflammatory Bowel Diseases|February 27, 2016
Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent MalignancyFlorian Poullenot, Philippe Seksik, Laurent Beaugerie, et al.
Gut|November 25, 2024
Top-down infliximab plus azathioprine versus azathioprine alone in patients with acute severe ulcerative colitis responsive to intravenous steroids: a parallel, open-label randomised controlled trial, the ACTIVE trialAurelien Amiot, Philippe Seksik, Antoine Meyer, et al.
Pageof 19